nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM1—GPCR ligand binding—GHRL—metabolic syndrome X	0.00286	0.00286	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—GHRL—metabolic syndrome X	0.00285	0.00285	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—GHRL—metabolic syndrome X	0.00282	0.00282	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00282	0.00282	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—PPARG—metabolic syndrome X	0.0028	0.0028	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00276	0.00276	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00275	0.00275	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00272	0.00272	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CNR1—metabolic syndrome X	0.00271	0.00271	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CNR1—metabolic syndrome X	0.0027	0.0027	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.0027	0.0027	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CNR1—metabolic syndrome X	0.00267	0.00267	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—FMO3—metabolic syndrome X	0.00266	0.00266	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—SERPINE1—metabolic syndrome X	0.00253	0.00253	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—AGT—metabolic syndrome X	0.00249	0.00249	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00242	0.00242	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MLXIPL—metabolic syndrome X	0.00237	0.00237	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—EPHX2—metabolic syndrome X	0.00237	0.00237	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00231	0.00231	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.0023	0.0023	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—GHRL—metabolic syndrome X	0.0023	0.0023	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00228	0.00228	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—G6PC2—metabolic syndrome X	0.00223	0.00223	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HTR2C—metabolic syndrome X	0.0022	0.0022	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00219	0.00219	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00218	0.00218	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00217	0.00217	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00216	0.00216	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CCL5—metabolic syndrome X	0.0021	0.0021	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CCL5—metabolic syndrome X	0.00209	0.00209	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—GHRL—metabolic syndrome X	0.00208	0.00208	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CCL5—metabolic syndrome X	0.00207	0.00207	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CCL2—metabolic syndrome X	0.00205	0.00205	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00199	0.00199	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00198	0.00198	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CNR1—metabolic syndrome X	0.00197	0.00197	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00196	0.00196	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.0019	0.0019	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—FABP4—metabolic syndrome X	0.0019	0.0019	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00189	0.00189	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00187	0.00187	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HDAC3—metabolic syndrome X	0.00186	0.00186	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.0018	0.0018	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—HSD11B1—metabolic syndrome X	0.0018	0.0018	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—AGT—metabolic syndrome X	0.00176	0.00176	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—AGT—metabolic syndrome X	0.00175	0.00175	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—AGT—metabolic syndrome X	0.00173	0.00173	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.0017	0.0017	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.0017	0.0017	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00168	0.00168	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00168	0.00168	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00167	0.00167	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TRIB3—metabolic syndrome X	0.00162	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RBP4—metabolic syndrome X	0.00162	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.00162	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00162	0.00162	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00161	0.00161	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—G6PD—metabolic syndrome X	0.0016	0.0016	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.0016	0.0016	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—HDAC3—metabolic syndrome X	0.00157	0.00157	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00155	0.00155	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00154	0.00154	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00153	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GCKR—metabolic syndrome X	0.00153	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—LPA—metabolic syndrome X	0.00153	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL5—metabolic syndrome X	0.00153	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00153	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00153	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00152	0.00152	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00151	0.00151	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PLA2G6—metabolic syndrome X	0.00148	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—GHRL—metabolic syndrome X	0.00147	0.00147	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOA5—metabolic syndrome X	0.00147	0.00147	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—GHRL—metabolic syndrome X	0.00146	0.00146	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.00145	0.00145	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—GHRL—metabolic syndrome X	0.00145	0.00145	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CCL2—metabolic syndrome X	0.00145	0.00145	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CCL2—metabolic syndrome X	0.00144	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOC3—metabolic syndrome X	0.00144	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CCL2—metabolic syndrome X	0.00143	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AGT—metabolic syndrome X	0.00141	0.00141	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CNR1—metabolic syndrome X	0.00139	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CNR1—metabolic syndrome X	0.00139	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CNR1—metabolic syndrome X	0.00137	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—TRIB3—metabolic syndrome X	0.00136	0.00136	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HDAC3—metabolic syndrome X	0.00131	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HDAC3—metabolic syndrome X	0.00131	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HTR2C—metabolic syndrome X	0.0013	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HDAC3—metabolic syndrome X	0.0013	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AGT—metabolic syndrome X	0.00128	0.00128	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CYBA—metabolic syndrome X	0.00126	0.00126	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GHRL—metabolic syndrome X	0.00123	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NAMPT—metabolic syndrome X	0.00122	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—LIPC—metabolic syndrome X	0.00122	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GCK—metabolic syndrome X	0.00122	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOC3—metabolic syndrome X	0.00121	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—IL6—metabolic syndrome X	0.0012	0.0012	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00119	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00118	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00117	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CETP—metabolic syndrome X	0.00117	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00117	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00117	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CNR1—metabolic syndrome X	0.00117	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00116	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TRIB3—metabolic syndrome X	0.00114	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RBP4—metabolic syndrome X	0.00114	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TRIB3—metabolic syndrome X	0.00114	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RBP4—metabolic syndrome X	0.00114	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.00114	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.00114	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TRIB3—metabolic syndrome X	0.00113	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RBP4—metabolic syndrome X	0.00113	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—SCARB1—metabolic syndrome X	0.00112	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—SREBF1—metabolic syndrome X	0.00109	0.00109	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL5—metabolic syndrome X	0.00108	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL5—metabolic syndrome X	0.00107	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00107	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00107	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL5—metabolic syndrome X	0.00106	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GOT2—metabolic syndrome X	0.00106	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—HMGCR—metabolic syndrome X	0.00106	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00106	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL2—metabolic syndrome X	0.00105	0.00105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOC3—metabolic syndrome X	0.00101	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOC3—metabolic syndrome X	0.00101	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOC3—metabolic syndrome X	0.001	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000992	0.000992	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AGT—metabolic syndrome X	0.000989	0.000989	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AGT—metabolic syndrome X	0.000979	0.000979	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF2—metabolic syndrome X	0.000953	0.000953	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ABCA1—metabolic syndrome X	0.000945	0.000945	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—SLC2A4—metabolic syndrome X	0.000945	0.000945	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOB—metabolic syndrome X	0.000925	0.000925	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GGT1—metabolic syndrome X	0.000915	0.000915	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GOT1—metabolic syndrome X	0.000915	0.000915	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000914	0.000914	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR2C—metabolic syndrome X	0.000912	0.000912	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL5—metabolic syndrome X	0.000904	0.000904	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR2C—metabolic syndrome X	0.000903	0.000903	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AGT—metabolic syndrome X	0.000901	0.000901	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.0009	0.0009	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AGT—metabolic syndrome X	0.000898	0.000898	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AGT—metabolic syndrome X	0.000889	0.000889	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CYBA—metabolic syndrome X	0.000886	0.000886	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LPL—metabolic syndrome X	0.000884	0.000884	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CYBA—metabolic syndrome X	0.000883	0.000883	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CYBA—metabolic syndrome X	0.000874	0.000874	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GHRL—metabolic syndrome X	0.000867	0.000867	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GHRL—metabolic syndrome X	0.000864	0.000864	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GHRL—metabolic syndrome X	0.000856	0.000856	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CNR1—metabolic syndrome X	0.000821	0.000821	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CNR1—metabolic syndrome X	0.000818	0.000818	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CNR1—metabolic syndrome X	0.00081	0.00081	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOB—metabolic syndrome X	0.000777	0.000777	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AGT—metabolic syndrome X	0.000756	0.000756	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PLA2G4A—metabolic syndrome X	0.000756	0.000756	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000742	0.000742	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—LPL—metabolic syndrome X	0.000742	0.000742	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LEP—metabolic syndrome X	0.000741	0.000741	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOE—metabolic syndrome X	0.000741	0.000741	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL2—metabolic syndrome X	0.00074	0.00074	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000732	0.000732	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOA1—metabolic syndrome X	0.000732	0.000732	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CD36—metabolic syndrome X	0.000705	0.000705	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF2—metabolic syndrome X	0.000671	0.000671	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF2—metabolic syndrome X	0.000669	0.000669	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF2—metabolic syndrome X	0.000663	0.000663	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IRS1—metabolic syndrome X	0.000661	0.000661	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARA—metabolic syndrome X	0.000655	0.000655	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOB—metabolic syndrome X	0.000652	0.000652	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOB—metabolic syndrome X	0.00065	0.00065	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOB—metabolic syndrome X	0.000643	0.000643	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL5—metabolic syndrome X	0.000636	0.000636	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AGT—metabolic syndrome X	0.000635	0.000635	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL5—metabolic syndrome X	0.000634	0.000634	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000634	0.000634	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—INS—metabolic syndrome X	0.000633	0.000633	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000632	0.000632	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL5—metabolic syndrome X	0.000628	0.000628	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000626	0.000626	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL2—metabolic syndrome X	0.000623	0.000623	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LPL—metabolic syndrome X	0.000622	0.000622	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—metabolic syndrome X	0.000622	0.000622	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LPL—metabolic syndrome X	0.00062	0.00062	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOA1—metabolic syndrome X	0.000615	0.000615	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LPL—metabolic syndrome X	0.000614	0.000614	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1—metabolic syndrome X	0.000612	0.000612	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000581	0.000581	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOS3—metabolic syndrome X	0.000555	0.000555	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARG—metabolic syndrome X	0.000542	0.000542	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AGT—metabolic syndrome X	0.000532	0.000532	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—INS—metabolic syndrome X	0.000531	0.000531	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AGT—metabolic syndrome X	0.000531	0.000531	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AGT—metabolic syndrome X	0.000525	0.000525	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LEP—metabolic syndrome X	0.000522	0.000522	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—metabolic syndrome X	0.000522	0.000522	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—metabolic syndrome X	0.00052	0.00052	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LEP—metabolic syndrome X	0.00052	0.00052	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOA1—metabolic syndrome X	0.000516	0.000516	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—metabolic syndrome X	0.000515	0.000515	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LEP—metabolic syndrome X	0.000515	0.000515	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOA1—metabolic syndrome X	0.000514	0.000514	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOA1—metabolic syndrome X	0.000509	0.000509	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—metabolic syndrome X	0.000487	0.000487	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000475	0.000475	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—metabolic syndrome X	0.000468	0.000468	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NOS3—metabolic syndrome X	0.000466	0.000466	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	0.000465	0.000465	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	0.000464	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	0.000459	0.000459	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—INS—metabolic syndrome X	0.000446	0.000446	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—INS—metabolic syndrome X	0.000444	0.000444	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—INS—metabolic syndrome X	0.00044	0.00044	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	0.000438	0.000438	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	0.000437	0.000437	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	0.000433	0.000433	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	0.000432	0.000432	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	0.000431	0.000431	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	0.00043	0.00043	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—metabolic syndrome X	0.000426	0.000426	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	0.000425	0.000425	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000409	0.000409	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000408	0.000408	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000404	0.000404	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	0.000391	0.000391	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	0.000389	0.000389	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	0.000386	0.000386	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	0.000367	0.000367	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000335	0.000335	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000334	0.000334	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	0.00033	0.00033	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	0.00033	0.00033	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	0.000329	0.000329	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	0.000325	0.000325	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	0.000304	0.000304	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	0.000303	0.000303	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	0.0003	0.0003	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	0.000276	0.000276	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	0.000258	0.000258	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	0.000258	0.000258	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	0.000255	0.000255	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	0.000255	0.000255	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—metabolic syndrome X	0.000214	0.000214	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	0.000195	0.000195	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	0.000194	0.000194	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	0.000192	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	0.00018	0.00018	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	0.000179	0.000179	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	0.000177	0.000177	CbGpPWpGaD
